Related Experiment Video
Updated: May 22, 2026

08:27
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Prediction models in women with postmenopausal bleeding: a systematic review
Nehalennia van Hanegem1, Maria C Breijer, Brent C Opmeer
1Department of Obstetrics & Gynecology, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, the Netherlands. lennievhanegem@gmail.com
Women'S Health (London, England)
|May 5, 2012
Summary
Postmenopausal bleeding may indicate endometrial cancer risk. This review found prediction models can help identify high-risk patients, guiding further diagnostic testing for endometrial carcinoma.
Area of Science:
- Gynecology
- Oncology
- Medical Diagnostics
Background:
- Postmenopausal bleeding is a key symptom associated with an increased risk of endometrial cancer.
- Accurate risk stratification is crucial for timely diagnosis and management of endometrial carcinoma.
Purpose of the Study:
- To review and assess existing prediction models for endometrial cancer in women experiencing postmenopausal bleeding.
- To identify key predictor variables and evaluate the performance of these models.
Main Methods:
- Systematic literature search to identify prognostic studies on endometrial cancer prediction.
- Quality assessment, development phase evaluation, and performance analysis of identified models.
- Identification of significant predictor variables from the reviewed studies.
Main Results:
- Nine prognostic studies were included, with varying quality and development phases.
- Models incorporating power Doppler demonstrated the best internal validation performance.
- No models underwent external validation or impact analysis, limiting generalizability.
Conclusions:
- Distinguishing between low-risk and high-risk patients with postmenopausal bleeding is a critical first step.
- Further (invasive) testing is recommended for patients identified as high-risk for endometrial carcinoma.
- Accessible and validated prediction models are needed for improved clinical decision-making.